Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ABLX

Ablynx (ABLX) Stock Price, News & Analysis

Ablynx logo

About Ablynx Stock (NASDAQ:ABLX)

Advanced Chart

Key Stats

Today's Range
$52.87
$52.87
50-Day Range
N/A
52-Week Range
$17.75
$55.29
Volume
N/A
Average Volume
249,005 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ABLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ablynx and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ABLX Stock News Headlines

BREAKING: The House just passed 3 pro-crypto bills!
THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. tc pixel
ABLX News
Ablynx NV ADR (ABLX)
Ablynx NV (EBR:ABLX): What Does The Future Look Like?
See More Headlines

ABLX Stock Analysis - Frequently Asked Questions

Ablynx (ABLX) raised $151 million in an IPO on Wednesday, October 25th 2017. The company issued 7,200,000 shares at $20.95 per share. BofA Merrill Lynch, J.P. Morgan and Jefferies acted as the underwriters for the IPO and Baird, Bryan, Garnier and Ladenburg Thalmann were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ablynx investors own include Galapagos (GLPG), argenex (ARGX), Ablynx (ABLYF), Gilead Sciences (GILD), AbbVie (ABBV), Bristol Myers Squibb (BMY) and Aurora Cannabis (ACBFF).

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:ABLX
CIK
N/A
Phone
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Optionable
Beta
N/A
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:ABLX) was last updated on 8/27/2025 by MarketBeat.com Staff
From Our Partners